The objective of the study was to investigate the anti-tumour effect of ethanol extract of Solanum lyratum Thunb. in S 180 tumour-bearing mice, and to preliminarily explore its mechanism of action. Methods: Mice were made into S 180 solid tumour model, grouped and administered. Tumour inhibition rate was measured by harvesting the tumours. Serum IL-2, TNF-a contents were measured by taking blood samples, and thymus index and spleen index were measured by harvesting the thymus and spleen. The results showed that the Solanum lyratum Thunb. extract had certain tumour inhibitory effect, which can elevate the serum IL-2, TNF-a contents, and increase the thymus and spleen indices to a certain extent. The study concluded that Solanum lyratum Thunb. extract has certain in vivo anti-tumour effect which may be exerted through enhancing the body immunity.
Effect of Solanum lyratum Thunb. extract on body weight of mice
The changes in body weight of mice before and after the experiment are shown in Table 2 . Except for the CTX group where weight gain is not obvious, body weights were significantly increased in all of the experimental groups. But the amount of increase is less when compared with the model group, and the amount of increase is basically negatively correlated with the dose. 
Effect of Solanum lyratum Thunb. extract on tumour weight and tumour inhibition rate
The results for the effect of Solanum lyratum Thunb. extract on tumour weight and tumour inhibition rate are as shown in Table 3 . There is a highly significant difference (P<0.01) in tumour weight of the Solanum lyratum Thunb.
high-dose group compared with the model group. Tumour weight of Solanum lyratum Thunb. medium-dose group also showed a significant difference (P<0.05) compared with the model group, and the tumour inhibition rates of the two groups were both greater than 30%, suggesting that the Solanum lyratum Thunb. extract has a significant inhibitory effect on solid tumour in S 180 tumour-bearing mice. In the Solanum lyratum Thunb. low-dose group, tumour weight was also reduced compared with the model group, but there was no significant difference.
Effect of Solanum lyratum Thunb. extract on serum IL-2 and TNF-a contents in mice
The effect of Solanum lyratum Thunb. extract on serum IL-2 and TNF-a contents in mice is as shown in Table 4 .
Compared with the model group, IL-2 level was decreased (P<0.01) and TNF-a was slightly increased but not significant in CTX group. IL-2, TNF-a contents were increased greatly (P<0.01) in Solanum lyratum Thunb. high-dose group. IL-2, TNF-a contents were also increased significantly (P<0.05 and P<0.01) in Solanum lyratum Thunb. medium-dose group. IL-2 was not changed obviously in Solanum lyratum Thunb. low-dose group. From this result, we can see that the Solanum lyratum Thunb.
extract can increase IL-2, TNF-a contents, thereby enhancing the body's ability to kill tumour cells, and exerting the inhibitory effect. 
Effect of Solanum lyratum Thunb. extract on immune organ thymus index and spleen index in S 180

tumour-bearing mice
The effect of Solanum lyratum Thunb. extract on immune organ thymus index and spleen index in S 180 tumour-bearing mice is shown in Table 5 . Compared with the model group, thymus and spleen weights were 
Discussion
As an anticancer drug, CTX has side effects such as leucopoenia, and decreased immune function (Jia and Lu, 1996) .
Body weight is the most direct reflection of drug toxicity in the S 180 sarcoma experiment. After tumour weight of mice in CTX group and negative group was removed respectively, the body weight of mice in CTX group was 3-5 g lighter than that of the negative group, while the body weight of mice in experimental group was 3-5 g heavier than negative group after removal of tumour weight of mice in experimental group and negative group. Therefore, although Solanum lyratum Thunb. is toxic, its toxicity is far less than CTX. Inhibition of tumour growth and shrinkage of tumour size is an important indicator in evaluating the efficacy of anticancer therapy of antineoplastic drugs. This experiment demonstrated that the Solanum lyratum Thunb. extract can exert inhibitory effect on growth of tumours in S180 tumour-bearing mice. And based on its in vivo antitumour effect, its effect on immune function was further explored, and it was initially confirmed that the extract has the effect of enhancing immune function. Its exact mechanism of action still needs more in-depth studies.
